BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 2881966)

  • 1. Modified responses to recipient and donor B cells by genetically donor T cells from human haploidentical bone marrow chimeras.
    Schiff SE; Buckley RH
    J Immunol; 1987 Apr; 138(7):2088-94. PubMed ID: 2881966
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modified MHC restriction of donor-origin T cells in humans with severe combined immunodeficiency transplanted with haploidentical bone marrow stem cells.
    Roberts JL; Volkman DJ; Buckley RH
    J Immunol; 1989 Sep; 143(5):1575-9. PubMed ID: 2474604
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development of immunity in human severe primary T cell deficiency following haploidentical bone marrow stem cell transplantation.
    Buckley RH; Schiff SE; Sampson HA; Schiff RI; Markert ML; Knutsen AP; Hershfield MS; Huang AT; Mickey GH; Ward FE
    J Immunol; 1986 Apr; 136(7):2398-407. PubMed ID: 2869085
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development of tolerance after haplocompatible T-depleted bone marrow transplantation.
    Merino A; Dror Y; Benkerrou M; Colombe BW; Cowan MJ
    Bone Marrow Transplant; 1993 Nov; 12(5):483-8. PubMed ID: 8298559
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Self-tolerance to host and donor following HLA-mismatched bone marrow transplantation.
    De Villartay JP; Griscelli C; Fischer A
    Eur J Immunol; 1986 Feb; 16(2):117-22. PubMed ID: 3514234
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of selective T cell depletion of host and/or donor bone marrow on lymphopoietic repopulation, tolerance, and graft-vs-host disease in mixed allogeneic chimeras (B10 + B10.D2----B10).
    Ildstad ST; Wren SM; Bluestone JA; Barbieri SA; Stephany D; Sachs DH
    J Immunol; 1986 Jan; 136(1):28-33. PubMed ID: 2933464
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The evolution of MHC restrictions in antigen recognition by T cells in a haploidentical bone marrow transplant recipient.
    Geha RS; Rosen FS
    J Immunol; 1989 Jul; 143(1):84-8. PubMed ID: 2567317
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chimerism and tolerance to host and donor in severe combined immunodeficiencies transplanted with fetal liver stem cells.
    Bacchetta R; Vandekerckhove BA; Touraine JL; Bigler M; Martino S; Gebuhrer L; de Vries JE; Spits H; Roncarolo MG
    J Clin Invest; 1993 Mar; 91(3):1067-78. PubMed ID: 8450037
    [TBL] [Abstract][Full Text] [Related]  

  • 9. T cell differentiation/maturation of CD34+ stem cells from HIV-seropositive hemophiliacs in cultured thymic epithelial fragments.
    Ruiz M; Roodman ST; Bouhasin JD; Knutsen AP
    Stem Cells; 1996 Jan; 14(1):132-45. PubMed ID: 8820959
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [T-cell-depleted HLA non-identical bone marrow transplantation in the child: prevention of graft-versus-host reaction by administration of donor T lymphocytes alloreactive against the recipient].
    Cavazzana-Calvo M; André-Schmutz I; Hacein-Bey S; Schindler J; Vitetta H; Dupuis S; Quartier P; Chedeville G; Vilmer E; Casanova JL; Buffet R; Caillat-Zucman S; Radford I; Le Deist F; Fischer A
    J Soc Biol; 2001; 195(1):65-8. PubMed ID: 11530503
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hematopoietic stem-cell transplantation for the treatment of severe combined immunodeficiency.
    Buckley RH; Schiff SE; Schiff RI; Markert L; Williams LW; Roberts JL; Myers LA; Ward FE
    N Engl J Med; 1999 Feb; 340(7):508-16. PubMed ID: 10021471
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Haploidentical bone marrow stem cell transplantation in human severe combined immunodeficiency.
    Buckley RH; Schiff SE; Schiff RI; Roberts JL; Markert ML; Peters W; Williams LW; Ward FE
    Semin Hematol; 1993 Oct; 30(4 Suppl 4):92-101; discussion 102-4. PubMed ID: 7905667
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immune responses and their regulation by donor bone marrow cells in clinical organ transplantation.
    Mathew JM; Garcia-Morales RO; Carreno M; Jin Y; Fuller L; Blomberg B; Cirocco R; Burke GW; Ciancio G; Ricordi C; Esquenazi V; Tzakis AG; Miller J
    Transpl Immunol; 2003; 11(3-4):307-21. PubMed ID: 12967784
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Allogeneic bone marrow transplantation: relation between chimaerism and immunity.
    Vossen J
    Verh K Acad Geneeskd Belg; 1998; 60(2):111-43; discussion 143-5. PubMed ID: 9703764
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Leucyl-leucine methyl ester treatment of donor cells permits establishment of immunocompetent parent----F1 chimeras that are selectively tolerant of host alloantigens.
    Thiele DL; Calomeni JA; Lipsky PE
    J Immunol; 1987 Oct; 139(7):2137-42. PubMed ID: 3309052
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Donor leukocyte infusions for recurrent hematologic malignancies after allogeneic bone marrow transplantation: impact of infused and residual donor T cells.
    Verdonck LF; Petersen EJ; Lokhorst HM; Nieuwenhuis HK; Dekker AW; Tilanus MG; de Weger RA
    Bone Marrow Transplant; 1998 Dec; 22(11):1057-63. PubMed ID: 9877267
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Autologous B lymphoblastoid cell lines and long-term cultured T cells as stimulators in the mixed lymphocyte reaction: analysis of the role of HLA class II antigens as stimulatory molecules.
    Santoli D; Radka SF; Igarashi M; Kreider BL; Ferrone S
    J Immunol; 1986 Jul; 137(2):400-7. PubMed ID: 2941479
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Selective depletion of alloreactive T lymphocytes using patient-derived nonhematopoietic stimulator cells in allograft engineering.
    Nonn M; Herr W; Khan S; Todorova M; Link I; Thies J; Distler E; Kaltwasser M; Hoffmann J; Huber C; Hartwig UF
    Transplantation; 2008 Nov; 86(10):1427-35. PubMed ID: 19034014
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Graft vs graft reaction resulting in the elimination of maternal cells in a SCID patient with maternofetal GVHd after an HLA identical bone marrow transplantation.
    Le Deist F; Raffoux C; Griscelli C; Fischer A
    J Immunol; 1987 Jan; 138(2):423-7. PubMed ID: 3540121
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mixed chimera converted into full donor chimera with powerful graft-versus-leukemia effects but no graft-versus-host disease after non T cell-depleted HLA-mismatched peripheral blood stem cell transplantation.
    Wu BY; Guo KY; Song CY; Yang ; Li D
    Bone Marrow Transplant; 2000 Sep; 26(6):691-3. PubMed ID: 11035376
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.